Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.57 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.57 |
| ▸ | HTT | P42858 | 4/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.57 |
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | PRNP | P04156 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | PPARG | P37231 | 1/20 | 0.57 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.57 |
| ▸ | NR2E3 | Q9Y5X4 | 1/20 | 0.57 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.57 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | KRAS | P01116 | 4/20 | 0.41 |
| ▸ | EGFR | P00533 | 1/20 | 0.41 |
| ▸ | HMOX2 | P30519 | 1/20 | 0.41 |
| ▸ | CRYZ | Q08257 | 1/20 | 0.41 |
| ▸ | VAT1 | Q99536 | 1/20 | 0.41 |
| ▸ | RTN4 | Q9NQC3 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19695793 | 0.87 | HTT (0.49) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL17030848 | 0.86 | MAPT (0.59) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL22973128 | 0.84 | KRAS (0.41) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL16637106 | 0.83 | KRAS (0.51) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL17030874 | 0.81 | SMN1; SMN2 (0.44) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL27147161 | 0.81 | SMN1; SMN2 (0.44) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL16636828 | 0.80 | KRAS (0.66) | KRASEGFRHMOX2CRYZVAT1 | |
| SCHEMBL30600136 | 0.77 | MAPT (0.48) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL18133893 | 0.77 | TLR7 (0.46) | MAPTNPSR1HTTTSHRLMNA | |
| SCHEMBL16636962 | 0.77 | KIT (0.50) | MAPTHTTLMNAKRASEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180118757-A1 | SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C | ARAXES PHARMA LLC | 2018-05-03 | — | — | US | disclosed |
| US-9840516-B2 | Substituted quinazolines as inhibitors of KRAS G12C | ARAXES PHARMA LLC (US) | 2017-12-12 | — | — | US | disclosed |
| US-20150239900-A1 | INHIBITORS OF KRAS G12C | ARAXES PHARMA LLC | 2015-08-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180118757-A1 | SUBSTITUTED QUINAZOLINES AS INHIBITORS OF KRAS G12C | KRAS, NRAS, HRAS | MAPT 761/4885NPSR1 4618/4885HTT 2370/4885 |
| US-20150239900-A1 | INHIBITORS OF KRAS G12C | KRAS, NRAS, HRAS | MAPT 279/4885NPSR1 4528/4885HTT 2353/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.